Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.4 % BTX opened at $1.80 on Friday. The company has a market cap of $105.59 million, a price-to-earnings ratio of -0.79 and […]
More Stories
Fiera Capital (OTCMKTS:FRRPF) Stock Price Down 0.8% – What’s Next?
Fiera Capital Co. (OTCMKTS:FRRPF – Get Free Report)’s stock price traded down 0.8% during mid-day trading on Wednesday . The...
Sumitomo Chemical (OTCMKTS:SOMMY) Trading Down 1.1% – Time to Sell?
Sumitomo Chemical Company, Limited (OTCMKTS:SOMMY – Get Free Report)’s stock price fell 1.1% during trading on Wednesday . The company...
Comparing TFI International (NYSE:TFII) and BingEx (NASDAQ:FLX)
TFI International (NYSE:TFII – Get Free Report) and BingEx (NASDAQ:FLX – Get Free Report) are both transportation companies, but which...
Ottawa Bancorp (OTCMKTS:OTTW) Stock Price Down 0.3% – Time to Sell?
Ottawa Bancorp, Inc. (OTCMKTS:OTTW – Get Free Report)’s stock price was down 0.3% during trading on Wednesday . The company...
Deutsche Wohnen (OTCMKTS:DTCWY) Shares Down 4.8% – Here’s Why
Deutsche Wohnen SE (OTCMKTS:DTCWY – Get Free Report)’s share price dropped 4.8% during mid-day trading on Wednesday . The company...
RUA Life Sciences (LON:RUA) Trading Up 4.4% – What’s Next?
RUA Life Sciences plc (LON:RUA – Get Free Report)’s share price rose 4.4% during trading on Wednesday . The stock...